Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Bayout case

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Mar 17, 2023 11:27am

94 Views

Post# 35345014

RE:RE:RE:RE:RE:RE:RE:Bayout case

Not that it could'nt or shoud'nt occur considering the earning power the company has if it does cut the overhead overthere. The Pharma's have hoards of cash and can buy everything they want to fill the pipeline at huge discount at the moment. Buying a Nash P2/3 that is safe with a casflow safeguard and Cancer lottery ticket for free is king od difficult to pass on. And now whatever poison pill they've put in place it's safe to say we all want a faster way out and let other discover the potential the futur holds.

<< Previous

Bullboard Posts

Next >>

Viva Gold brings new drill program and updated PEA to Nevada project